X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (109) 109
index medicus (98) 98
humans (90) 90
hematology (88) 88
male (59) 59
middle aged (59) 59
female (56) 56
aged (53) 53
adult (51) 51
leukemia (48) 48
acute myeloid leukemia (42) 42
acute myeloid-leukemia (39) 39
cancer (39) 39
aged, 80 and over (37) 37
mutation (37) 37
article (36) 36
leukemia, myeloid, acute - drug therapy (32) 32
leukemia, myeloid, acute - genetics (30) 30
prognosis (30) 30
treatment outcome (30) 30
therapy (29) 29
chemotherapy (26) 26
aml (25) 25
myelodysplastic syndromes (25) 25
patients (24) 24
mutations (23) 23
leukemia, myeloid, acute - pathology (22) 22
acute myelogenous leukemia (21) 21
myeloid leukemia (20) 20
survival (19) 19
antineoplastic combined chemotherapy protocols - therapeutic use (18) 18
hematology, oncology and palliative medicine (18) 18
myelodysplastic syndrome (18) 18
young adult (18) 18
abridged index medicus (17) 17
analysis (16) 16
disease-free survival (16) 16
leukemia, myeloid, acute - mortality (16) 16
myelodysplastic syndromes - genetics (16) 16
adolescent (15) 15
bone marrow (14) 14
cytogenetics (14) 14
antineoplastic agents - therapeutic use (13) 13
cytarabine (13) 13
health aspects (13) 13
hemic and lymphatic diseases (13) 13
leukemia, myeloid, acute - diagnosis (13) 13
retrospective studies (13) 13
care and treatment (12) 12
follow-up studies (12) 12
genetic aspects (12) 12
isocitrate dehydrogenase - genetics (12) 12
minimal residual disease (12) 12
older patients (12) 12
survival analysis (12) 12
bone marrow - pathology (11) 11
risk factors (11) 11
survival rate (11) 11
adult patients (10) 10
antineoplastic agents - adverse effects (10) 10
diagnosis (10) 10
gene expression (10) 10
myelodysplastic syndromes - pathology (10) 10
pathology (10) 10
prognostic-significance (10) 10
research (10) 10
decitabine (9) 9
flow cytometry (9) 9
intensive chemotherapy (9) 9
medical prognosis (9) 9
multivariate analysis (9) 9
neoplasms (9) 9
remission induction (9) 9
tumors (9) 9
apoptosis (8) 8
classification (8) 8
drug therapy (8) 8
international working group (8) 8
kaplan-meier estimate (8) 8
malignancies (8) 8
prognostic scoring system (8) 8
remission (8) 8
tyrosine (8) 8
abnormalities (7) 7
abt-199 (7) 7
acute promyelocytic leukemia (7) 7
adults (7) 7
age (7) 7
animals (7) 7
clinical trials (7) 7
dna methylation (7) 7
gene mutations (7) 7
genes (7) 7
leukemia, myeloid, acute - therapy (7) 7
mds (7) 7
myelodysplastic syndromes - drug therapy (7) 7
myelodysplastic syndromes - mortality (7) 7
open-label (7) 7
outcomes (7) 7
protein-tyrosine kinase (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 04/2018, Volume 16, Issue 4, pp. 247 - 249
Journal Article
Clinical advances in hematology & oncology : H&O, ISSN 1543-0790, 03/2018, Volume 16, Issue 3, pp. 21 - 23
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 08/2017, Volume 18, Issue 8, p. 1618
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 02/2019, Volume 16, Issue 2, pp. 73 - 74
In 2018, the acute myeloid leukaemia treatment landscape expanded notably, with several trials leading to the approval of novel targeted therapies.... 
ONCOLOGY | Tyrosine | Chemotherapy | Cytarabine | Daunorubicin | Leukemia | Clinical trials | Mutation | Gene expression | Ribonucleic acid--RNA | Patients | Isocitrate dehydrogenase | Protein-tyrosine kinase | Index Medicus
Journal Article
The Lancet Oncology, ISSN 1470-2045, 02/2018, Volume 19, Issue 2, pp. 216 - 228
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2018, Volume 378, Issue 25, pp. 2386 - 2398
Among patients with IDH1 -mutated relapsed or refractory leukemia, daily oral ivosidenib, an IDH1 inhibitor, induced molecular clearance of leukemic cells from... 
MEDICINE, GENERAL & INTERNAL | IDH2 MUTATIONS | METAANALYSIS | ACUTE MYELOID-LEUKEMIA | PROGNOSTIC-SIGNIFICANCE | DIFFERENTIATION | INHIBITOR | Glycine - analogs & derivatives | Recurrence | Follow-Up Studies | Glycine - adverse effects | Cell Count | Humans | Middle Aged | Pyridines - pharmacokinetics | Drug Resistance, Neoplasm | Male | Isocitrate Dehydrogenase - antagonists & inhibitors | Dose-Response Relationship, Drug | Enzyme Inhibitors - administration & dosage | Young Adult | Pyridines - adverse effects | Enzyme Inhibitors - pharmacokinetics | Aged, 80 and over | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Glycine - administration & dosage | Enzyme Inhibitors - adverse effects | Glycine - pharmacokinetics | Pyridines - administration & dosage | Administration, Oral | Isocitrate Dehydrogenase - genetics | Survival Rate | Remission Induction | Leukemia, Myeloid, Acute - mortality | Adolescent | Aged | Mutation | Hemoglobins - analysis | Leukemia, Myeloid, Acute - genetics | Usage | Myelocytic leukemia | Gene mutations | Physiological aspects | Genetic aspects | Nonlymphoid leukemia | Research | Drug therapy | Isocitrate dehydrogenase | Risk factors | Thrombocytopenia | Myeloid leukemia | Leukemia | FDA approval | Cancer therapies | Patients | Investigations | Leukocytosis | Collaboration | Point mutation | Remission | Acute myeloid leukemia | Drug dosages | Neutropenia | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 2017, Volume 39, Issue 2, pp. 359 - 367
Journal Article
Clinical Lymphoma, Myeloma & Leukemia, ISSN 2152-2650, 2016, Volume 16, pp. S128 - S129
Journal Article
Nature Communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 2670 - 12
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 18, Issue 1, pp. 100 - 111
Journal Article
Future Oncology, ISSN 1479-6694, 04/2018, Volume 14, Issue 10, pp. 979 - 993
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 15, pp. 1547 - 1555
Journal Article
Oncology Times, ISSN 0276-2234, 12/2015, Volume 37, Issue 24, pp. 14 - 15
Journal Article